Source: StreetInsider

Press Release: Quidel : QuidelOrtho to Participate in the Evercore ISI Conference

SAN DIEGO--(BUSINESS WIRE)-- QuidelOrtho Corporation (Nasdaq: QDEL) (QuidelOrtho), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine,...

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
Douglas C. Bryant's photo - President & CEO of Quidel

President & CEO

Douglas C. Bryant

CEO Approval Rating

74/100

Read more